<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Lin Q</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>In radiomics, high-throughput algorithms extract objective quantitative features from medical images. In this study, we evaluated CT-based radiomics features, clinical features, in-depth learning features, and a combination of features for predicting a good pathological response (GPR) in non-small cell lung cancer (NSCLC) patients receiving immunotherapy-based neoadjuvant therapy (NAT).&lt;h4>Materials and methods&lt;/h4>We reviewed 62 patients with NSCLC who received surgery after immunotherapy-based NAT and collected clinicopathological data and CT images before and after immunotherapy-based NAT. A series of image preprocessing was carried out on CT scanning images: tumor segmentation, conventional radiomics feature extraction, deep learning feature extraction, and normaliza</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>937277</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9577189</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.</pubmed_title><pmcid>PMC9577189</pmcid><pubmed_authors>Song QS</pubmed_authors><pubmed_authors>Lin Q</pubmed_authors><pubmed_authors>Tang YK</pubmed_authors><pubmed_authors>Wu HJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.</name><description>&lt;h4>Objectives&lt;/h4>In radiomics, high-throughput algorithms extract objective quantitative features from medical images. In this study, we evaluated CT-based radiomics features, clinical features, in-depth learning features, and a combination of features for predicting a good pathological response (GPR) in non-small cell lung cancer (NSCLC) patients receiving immunotherapy-based neoadjuvant therapy (NAT).&lt;h4>Materials and methods&lt;/h4>We reviewed 62 patients with NSCLC who received surgery after immunotherapy-based NAT and collected clinicopathological data and CT images before and after immunotherapy-based NAT. A series of image preprocessing was carried out on CT scanning images: tumor segmentation, conventional radiomics feature extraction, deep learning feature extraction, and normaliza</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T21:21:42.041Z</modification><creation>2025-04-19T21:21:42.041Z</creation></dates><accession>S-EPMC9577189</accession><cross_references><pubmed>36267975</pubmed><doi>10.3389/fonc.2022.937277</doi></cross_references></HashMap>